The effectiveness of combination therapy using meloxicam (Loxidol) and Cocarnit in the treatment of patients with chronic diseases of the musculoskeletal system during an exacerbation

Authors: O.V. Kuriata1, O.Yu. Sirenko1, T.K. Lysunets2, A.S. Lehkobyt2, A.S. Vorotylyshcheva2

1State Institution “Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine”, Dnipro, Ukraine
2Municipal Institution “І.І. Mechnikov Regional Clinical Hospital”, Dnipro, Ukraine

Abstract

The article deals with the issues of treatment for chronic diseases of the musculoskeletal system during the period of exacerbation. Attention was paid to the choice of a drug from the group of non-steroidal anti-inflammatory agents and a drug with metabolic action. Data are presented on the studies of the efficacy and safety of the combined administration of meloxicam (Loxidol) and Cocarnit.

Key words: musculoskeletal system; osteoarthritis; synovitis; seronegative arthropathy; rheumatoid arthritis; treatment

Article in PDF
ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
Опубліковано в журналі «Сучасна педіатрія. Україна» №8 (120) ’2021
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

Yes
No

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design